Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alla Dolnikov

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Current Gene Therapy|November 1, 2006
The role of IRF1 and IRF2 transcription factors in leukaemogenesisAilyn Choo, Patricia Palladinetti, Toby Passioura, et al.
Immunotargets and Therapy|May 6, 2021
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell TherapyNing Xu, Benjamin Tse, Lu Yang, et al.
Cancer Gene Therapy|September 23, 2003
A sensitive dual-fluorescence reporter system enables positive selection of ras suppressors by suppression of ras-induced apoptosisAlla Dolnikov, Sylvie Shen, Michelle Millington, et al.
Stem Cells (Dayton, Ohio)|October 21, 2010
GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expressionKap-Hyoun Ko, Tiffany Holmes, Patricia Palladinetti, et al.
Experimental Hematology|September 20, 2015
Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemiaAlla Dolnikov, Sylvie Shen, Guy Klamer, et al.
Experimental Hematology|June 15, 2010
Glycogen synthase kinase--3β inhibitors suppress leukemia cell growthEmma Y Song, Patricia Palladinetti, Guy Klamer, et al.
Stem Cells (Dayton, Ohio)|March 8, 2008
Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growthTiffany Holmes, Tracey A O'Brien, Robert Knight, et al.
Experimental Hematology|September 4, 2004
Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouseSylvie W Shen, Alla Dolnikov, Toby Passioura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2018
PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL XenograftsDavid C Bishop, Ning Xu, Benjamin Tse, et al.
Experimental Hematology|September 25, 2012
GSK3 inhibition prevents lethal GVHD in miceGuy Klamer, Sylvie Shen, Emma Song, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|November 1, 2006
The role of IRF1 and IRF2 transcription factors in leukaemogenesisAilyn Choo, Patricia Palladinetti, Toby Passioura, et al.
Immunotargets and Therapy|May 6, 2021
Priming Leukemia with 5-Azacytidine Enhances CAR T Cell TherapyNing Xu, Benjamin Tse, Lu Yang, et al.
Cancer Gene Therapy|September 23, 2003
A sensitive dual-fluorescence reporter system enables positive selection of ras suppressors by suppression of ras-induced apoptosisAlla Dolnikov, Sylvie Shen, Michelle Millington, et al.
Stem Cells (Dayton, Ohio)|October 21, 2010
GSK-3β inhibition promotes engraftment of ex vivo-expanded hematopoietic stem cells and modulates gene expressionKap-Hyoun Ko, Tiffany Holmes, Patricia Palladinetti, et al.
Experimental Hematology|September 20, 2015
Antileukemic potency of CD19-specific T cells against chemoresistant pediatric acute lymphoblastic leukemiaAlla Dolnikov, Sylvie Shen, Guy Klamer, et al.
Experimental Hematology|June 15, 2010
Glycogen synthase kinase--3β inhibitors suppress leukemia cell growthEmma Y Song, Patricia Palladinetti, Guy Klamer, et al.
Stem Cells (Dayton, Ohio)|March 8, 2008
Glycogen synthase kinase-3beta inhibition preserves hematopoietic stem cell activity and inhibits leukemic cell growthTiffany Holmes, Tracey A O'Brien, Robert Knight, et al.
Experimental Hematology|September 4, 2004
Mutant N-ras preferentially drives human CD34+ hematopoietic progenitor cells into myeloid differentiation and proliferation both in vitro and in the NOD/SCID mouseSylvie W Shen, Alla Dolnikov, Toby Passioura, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 5, 2018
PiggyBac-Engineered T Cells Expressing CD19-Specific CARs that Lack IgG1 Fc Spacers Have Potent Activity against B-ALL XenograftsDavid C Bishop, Ning Xu, Benjamin Tse, et al.
Experimental Hematology|September 25, 2012
GSK3 inhibition prevents lethal GVHD in miceGuy Klamer, Sylvie Shen, Emma Song, et al.
Pageof 3